Obesity

A new review highlights how rising childhood obesity, genetic susceptibility, and early-life gut microbiota changes contribute to youth-onset type 2 diabetes.

A recent study found that nearly half of parents of children with high weight reported concerns about disordered eating.

In a recent study, caregiver experiences, trust, and family values shaped decisions about GLP-1 medications for children with obesity.

GLP-1 receptor agonist use was associated with a lower risk of asthma exacerbations in adolescents with overweight or obesity.

Experts discuss how specialty pharmacy partnerships dramatically improved GLP-1 access, adherence, and workflow efficiency for teens with obesity.

Children diagnosed with COVID-19 gained more weight than COVID-negative peers, especially after diagnosis, during the pandemic.

Results from a cross-sectional study find large proportions of obesity-related conditions in US youth are attributable to obesity and, to a lesser extent, overweight.

Pharmacotherapy use for pediatric obesity rose after AAP’s 2023 guidelines, though overall rates remain low compared to nutrition counseling.

Richard Auchus, MD, PhD, highlights data showing that crinecerfont use in children with CAH can improve metabolic outcomes.

A new polygenic risk score enhances obesity risk prediction from childhood to adulthood, offering new insights for early intervention and prevention strategies.

In this article, we recap our top stories, expert interviews, and Q+A discussions from the 2025 Pediatric Academic Societies meeting.

In the phase 3 TRANSCEND trial, setmelanotide met the primary endpoint of a statistically significant and clinically meaningful BMI reduction compared to placebo.

On World Obesity Day, take this short quiz and test your knowledge of the AAP's clinical practice guideline to evaluate and treat children and adolescents with obesity.

Colleen Sloan, PA-C, RDN, emphasizes the importance of learning to spot added sugars, compare portion sizes, and recognize misleading marketing claims to give patients a practical tool to take ownership of their health.

According to a new study, racial and ethnic disparities were evident when counseling on nutrition, lifestyle, and weight among children with high blood pressure measurements.

"The greatest risk reductions were demonstrated in those who experienced obesity remission during childhood," stated study authors.

Across all years in the report, the CDC rated each physical activity trend with a color of red, indicating that trends are going in the "wrong direction."

The expanded indication is approved to reduce excess body weight and maintain reduction long-term in children 2 years and up with obesity due to BBS, POMC, or LEPR deficiency.

"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."

A decade after bariatric surgery, most teens maintained weight loss and reduced obesity-related conditions such as type 2 diabetes and hypertension.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from last week, all in one place.

The detected reduction in HRs for suicidal ideation among adolescents with obesity prescribed GLP1R suggests potential avenues for future research.

GLP-1 receptor agonists are increasingly being used to treat obesity in adolescents.

Kay Rhee, MD, discusses the challenges of pediatric obesity treatment, highlighting the role of biological and environmental factors, behavioral interventions, and the potential benefits of GLP-1 medications in weight management for children and teens.

Tanya Altmann, MD, discusses the growing issue of childhood obesity in the United States and the benefits of new weight management medications.